Belite Bio has filed proposed terms for a $36 million IPO. The firm is advancing treatment candidates for various eye diseases. Read more about the IPO here.
( read original story …)
The Taiwan NEWS
Belite Bio has filed proposed terms for a $36 million IPO. The firm is advancing treatment candidates for various eye diseases. Read more about the IPO here.
( read original story …)